<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 13-year-old girl with <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">preB-ALL</z:e> was admitted because of <z:hpo ids='HP_0002315'>headache</z:hpo> during maintenance therapy including L-asparaginase </plain></SENT>
<SENT sid="1" pm="."><plain>Magnetic resonance imaging revealed <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Coagulation studies showed decreased levels of fibrinogen, antithrombin-III and plasminogen </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was treated with antithrombin-III concentrates and fresh frozen plasma and recovered quickly </plain></SENT>
<SENT sid="4" pm="."><plain>These findings suggest that <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> induced by L-asparaginase is associated with the pathogenesis of <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
</text></document>